港股汽车股集体下跌 ，其中，长城汽车跌近7%，蔚来汽车、小鹏汽车跌超4.2%，奇瑞汽车、零跑汽 车、吉利汽车跌近4%，理想汽车、比亚迪股份、赛力斯均有跌幅。 消息上，中金发表报告指，展望2026年，预计内地汽车业政策延续之下内需面临一定挑战，海外销量稳 健增长。投资策略上，零部件优於整车，关注机器人、智能驾驶及数据中心液冷等AI相关布局带来的 盈利估值双升机遇。乘用车方面，该行指，两新政策托底，内需仍面临一定挑战。 另外，一份报告显示，2026年全球电动汽车销量增速预计将创下自2020年疫情冲击全球经济以来的最低 水平，因为摆脱燃油车的转型之路正面临新的障碍。据研究机构Benchmark Mineral Intelligence预测，由 于欧洲市场增长大幅放缓以及美国市场急速萎缩，2026年全球电动汽车销量(包括纯电动汽车和插电式 混合动力车)预计将仅增长13%至2400万辆，远低于2025年22%的预估增幅。 | 代码 | 名称 | 最新价 | 涨跌幅 ^ | | --- | --- | --- | --- | | 02333 | 长城汽车 | 14.090 | -6.81% | | 09866 | 蔚来- ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 中國環境資源集團有限公司 (於開曼群島註冊成立之有限公司) 呈交日期: 2026年1月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01130 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 3,000,000,000 | HKD | | 0.1 | HKD | | 300,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 3,000,000,000 | HKD | | 0.1 | HKD | ...

Market Overview - The Hong Kong stock market experienced fluctuations and adjustments, with the Hang Seng Index down 0.92% to 25,737.85 points, the Hang Seng Tech Index down 1.79% to 5,537.11 points, the National Enterprises Index down 1.2% to 8,970.29 points, and the Red Chip Index down 0.3% to 4,137.97 points due to the significant drop in US stocks last Friday [1] - Major technology stocks saw declines, with Alibaba down 2.73%, Tencent Holdings down 1.54%, JD Group down 1.12%, Xiaomi down 2.28%, NetEase down 0.18%, Meituan down 1.07%, Kuaishou down 3.85%, and Bilibili down 1.12% [1] - Insurance stocks performed well, with China Ping An reaching a four-year high, while the biopharmaceutical sector weakened, with Baijiazhensheng down over 6% [1] - Semiconductor stocks faced significant declines, with Huahong Semiconductor down over 6% [1] Company News - China Merchants Energy (01138.HK) signed shipbuilding contracts with Dalian China Merchants Heavy Industry, Yangzhou China Merchants Heavy Industry, and Guangdong China Merchants Heavy Industry for the construction of one ethylene ship and eighteen oil tankers, with a total cost of RMB 7.882 billion [2] - ZhongAn Online (06060.HK) reported a cumulative original insurance premium income of approximately RMB 32.904 billion for the first eleven months [3] - R&F Properties (02777.HK) achieved total sales revenue of approximately RMB 12.7 billion in the first eleven months, representing a year-on-year increase of 24.63% [4] - Yida China (03639.HK) reported a contract sales amount of approximately RMB 681 million for the first eleven months, a year-on-year decrease of 23.22% [5] - Kason International (00496.HK) signed a steel structure procurement contract with suppliers, involving an investment of RMB 43.5366 million [5] Clinical and Regulatory Updates - Boke Vision Cloud-B (02592.HK) successfully held a meeting after the second phase of clinical trials for CBT-004 [6] - Fuhong Hanlin (02696.HK) received acceptance from the National Medical Products Administration for the listing registration application of Hanshuo® in combination with chemotherapy for neoadjuvant/adjuvant treatment of gastric cancer, which has been included in priority review [6] - Shijiazhuang Pharmaceutical Group (01093.HK) received approval for a new indication for Donyi® (liposomal irinotecan injection) for first-line treatment in patients with metastatic pancreatic cancer [6] - Hengrui Medicine (01276) received a clinical trial approval notice for HRS-1780 tablets [8] Investment Insights - Guosen Securities indicated that the short-term adjustment in the Hong Kong stock market opens up space for a market rise in 2026, with net inflows from southbound funds exceeding RMB 110 billion in November [13] - Dongwu Securities highlighted that the main focus for Hong Kong stocks is on technology and cyclical sectors, while also paying attention to innovative drugs, suggesting a barbell allocation strategy due to potential macro and political risks [13] - CITIC Securities projected that the Hong Kong stock market will benefit from internal "14th Five-Year Plan" catalysts and external fiscal and monetary easing from major economies, expecting a sustainable upward trend in revenue and profit [13] - Dongwu Securities also forecasted a continued recovery in the Hong Kong stock market in 2026, citing expected interest rate cuts by the Federal Reserve and a temporary easing of Sino-US relations [14]

Market Overview - The Hong Kong stock market opened lower on December 15, with the Hang Seng Index down 1% at 25,718.14 points, the Hang Seng Tech Index down 1.34% at 5,562.67 points, and the State-Owned Enterprises Index down 1.09% at 8,980.13 points [1] - Major tech stocks declined, including Alibaba down 2.14%, Tencent down 1.62%, and JD.com down 0.61% [1] - The innovative drug sector saw several stocks open lower, with Genscript Biotech down 5.92% and Zai Lab down 3.48% [1] - Chinese brokerage stocks collectively fell, with Everbright Securities dropping over 1% [1] - The automotive sector also experienced declines, with Li Auto down over 2% and XPeng down nearly 2% [1] - However, three-child policy concept stocks and photovoltaic stocks mostly rose, with star stock Jinxin Fertility rising about 3% [1] Company News - China Merchants Energy (01138.HK) signed shipbuilding contracts for one ethylene ship and eighteen oil tankers, totaling RMB 7.882 billion [2] - ZhongAn Online (06060.HK) reported cumulative original insurance premium income of approximately RMB 32.904 billion for the first eleven months [3] - R&F Properties (02777.HK) achieved total sales revenue of approximately RMB 12.7 billion in the first eleven months, a year-on-year increase of 24.63% [4] - Yida China (03639.HK) reported contract sales amounting to approximately RMB 681 million in the first eleven months, a year-on-year decrease of 23.22% [5] - Bole Technology (02592.HK) successfully held a meeting after the second phase of clinical trials for CBT-004 [6] - Junshi Biosciences (02696.HK) received acceptance for its marketing application for Hansizhuang® in combination with chemotherapy for gastric cancer [6] - CSPC Pharmaceutical Group (01093.HK) received approval for a new indication for its drug, Donyin® (liposomal irinotecan injection), for first-line treatment in metastatic pancreatic cancer patients [6] - Biyuan (00926.HK) increased its investment in ERX to maintain a 3% stake to support innovative research and development of non-GLP-1 weight loss therapies [7] - Hengrui Medicine (01276) received approval for clinical trials for HRS-1780 tablets [8] - AVIC Industry (02357.HK) plans to acquire a 59.1816% partnership interest in Hangtou Yuhua for a consideration of RMB 202 million [9] - China Environmental Resources (01130.HK) intends to acquire 90% equity in Sichuan Yuanlai Shun Recycling Resources Co., Ltd. for RMB 9 million [10] - AVIC Industry (02357.HK) proposed to implement full circulation of H-shares [11] - Yabo Technology Holdings (08279.HK) signed a framework agreement with Alipay (Hangzhou) [12] Institutional Insights - Guosen Securities indicated that the short-term adjustment in the Hong Kong stock market opens up space for a market rise in 2026, with net inflows from southbound funds exceeding RMB 110 billion in November [13] - CITIC Securities noted strong performance in gold and silver, while other risk assets were weak, predicting a segmented market for precious metals in 2025 [13] - CITIC Securities also emphasized the importance of resource self-sufficiency in the lithium industry, highlighting the need for low-cost quality resources to navigate market cycles [14]

Company News - China COSCO Shipping Energy Transportation Co., Ltd. (中远海能) has signed shipbuilding contracts with Dalian COSCO Shipping Heavy Industry, Yangzhou COSCO Shipping Heavy Industry, and Guangdong COSCO Shipping Heavy Industry for the construction of one ethylene ship and eighteen oil tankers, with a total cost of RMB 7.882 billion [1] - ZhongAn Online P&C Insurance Co., Ltd. (众安在线) reported a total original insurance premium income of approximately RMB 32.904 billion for the first eleven months [2] - R&F Properties Co., Ltd. (富力地产) achieved total sales revenue of approximately RMB 12.7 billion in the first eleven months, representing a year-on-year increase of 24.63% [3] - Yida China Holdings Limited (亿达中国) reported a contracted sales amount of approximately RMB 681 million for the first eleven months, a year-on-year decrease of 23.22% [4] - Karsen International Holdings Limited (卡森国际) has entered into a steel structure procurement contract with suppliers, involving an investment of RMB 43.5366 million [4] Clinical and Regulatory Updates - Bolex Cloud-B (拨康视云-B) successfully held a meeting after the second phase of clinical trials for CBT-004 [5] - Innovent Biologics, Inc. (复宏汉霖) has had its application for the marketing registration of Hansizhuang® combined chemotherapy for gastric cancer accepted by the National Medical Products Administration, and it has been included in the priority review [5] - CSPC Pharmaceutical Group Limited (石药集团) received approval for a new indication for Donyi® (Irinotecan Liposome Injection) for first-line treatment in patients with metastatic pancreatic cancer [5] - Heng Rui Medicine (恒瑞医药) received a clinical trial approval notice for HRS-1780 tablets [7] Investment and Acquisition Activities - AVIC Aviation Industry Corporation (中航科工) plans to acquire a 59.1816% partnership interest in Hangtou Yuhua for a consideration of RMB 202 million [8] - China Environment Resources Holdings Limited (中国环境资源) intends to acquire 90% equity in Sichuan Yuanlai Shun Recycling Resources Co., Ltd. for RMB 9 million [9] - AVIC Aviation Industry Corporation (中航科工) has proposed to implement full circulation of H-shares [10] - Yabo Technology Holdings Limited (亚博科技控股) has entered into a framework agreement with Alipay (Hangzhou) [11] Financing and Buyback Activities - Yum China Holdings, Inc. (百胜中国) has entered into a share buyback agreement with a total repurchase amount of approximately USD 460 million, including about HKD 880 million under the Hong Kong plan, as part of a plan to return USD 1.5 billion to shareholders through dividends and share buybacks by 2026 [12] - Tencent Holdings Limited (腾讯控股) repurchased approximately 1.044 million shares for about HKD 636 million, with repurchase prices ranging from HKD 601.5 to HKD 616 [13] - Xuanwu Cloud (玄武云) repurchased 6,000 shares for a total of HKD 6,467.79, with prices between HKD 1.05 and HKD 1.07 [14] - China COSCO Shipping Holdings Co., Ltd. (中远海控) repurchased approximately 4.461 million shares for about HKD 60.8605 million, with prices ranging from HKD 13.38 to HKD 13.82 [15] - Geely Automobile Holdings Limited (吉利汽车) repurchased approximately 1.362 million shares for about HKD 23.9241 million, with prices between HKD 17.29 and HKD 17.82 [16] - China Anshun Energy (中国安储能源) plans to issue a total of 524 million shares at a discount of approximately 19.12%, aiming to raise about HKD 288.2 million [16]

于2025年12月12日，公司透过其全资附属公司与四川源莱顺订立股权转让协议，拟以900万元收购目标 公司90%股本权益。目标公司主要于中国从事可再生及可回收资源的回收(专注于产生可重用铜、铝、 橡胶及稀土永磁体之新能源摩托车后轮胎组件)及其他附属业务机会。紧接收购事项完成前，目标公司 由四川源莱顺全资拥有。 董事相信，收购事项代表一个战略机会，透过进军稀土材料回收这一优质且专业的领域(一个具备重大 全球前景及发展潜力的行业)，以加强及扩展集团的金属回收业务。收购事项使本集团涉足稀土业务， 能够获取优质稀土磁性材料，并在电动汽车及绿色技术等竞争激烈的市场中脱颖而出。董事认为，收购 事项令集团得以满足其多元化业务分部(包括金属回收及绿色市场应用)对先进材料及创新解决方案不断 增长的需求。 中国环境资源(01130)公布，有关就位于中华人民共和国的稀土项目的业务发展及其他附属业务机会的 潜在合作订立的谅解备忘录，于2025年12月12日(交易时段后)，公司与Goldwin Century订立终止协议， 订约方据此已共同同意终止谅解备忘录，并即时生效。订立谅解备忘录乃为公司提供框架，以对四川源 莱顺及其业务营运进行 ...

智通财经APP讯，中国环境资源(01130)公布，有关就位于中华人民共和国的稀土项目的业务发展及其他 附属业务机会的潜在合作订立的谅解备忘录，于2025年12月12日(交易时段后)，公司与Goldwin Century 订立终止协议，订约方据此已共同同意终止谅解备忘录，并即时生效。订立谅解备忘录乃为公司提供框 架，以对四川源莱顺及其业务营运进行尽职审查并探索潜在合作的可行性。订约方于进行进一步商业谈 判后厘定，直接收购四川源莱顺的主要营运附属公司四川源莱顺再生资源有限公司(目标公司)将更符合 现有金属回收业务的战略方向(公司在煺出香港金属回收业务后持续致力于探索香港以外同类业务机 会)。此举较先前拟进行的合作更有利于集团。收购将使集团得以直接控制并全面整合目标公司的业 务，从而更有效地把握稀土材料市场的协同效益及增长机会。因此，订约方共同同意终止已达成其初步 目的的谅解备忘录，并订立明确协议以进行收购事项。 于2025年12月12日，公司透过其全资附属公司与四川源莱顺订立股权转让协议，拟以900万元收购目标 公司90%股本权益。目标公司主要于中国从事可再生及可回收资源的回收(专注于产生可重用铜、铝、 橡胶及稀 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何 部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 CHINA ENVIRONMENTAL RESOURCES GROUP LIMITED 中國環境資源集團有限公司 （於開曼群島註冊成立之有限公司） （股份代號：1130） 內幕消息 終止諒解備忘錄 及 收購目標公司90%股本權益 本公佈乃由中國環境資源集團有限公司（「本公司」）根據香港聯合交易所有限公司證 券上市規則（「上市規則」）第13.09條及香港法例第571章證券及期貨條例第XIVA部 項下之內幕消息條文（定義見上市規則）作出。 茲提述本公司日期為二零二五年二月二十一日、二零二五年八月十九日及二零二五 年十一月十九日之公佈（「該等公佈」），內容有關就位於中華人民共和國之稀土項目 之業務發展及其他附屬業務機會之潛在合作訂立之諒解備忘錄。除文義另有所指 外，下文所用詞彙與該等公佈所界定者具有相同涵義。 終止諒解備忘錄 董事會宣佈，於二零二五年十二月十二日（交易時段後），本公司與Goldwin Cent ...

香港联交所最新资料显示，12月2日，曾阳庆增持中国环境资源(01130)3686万股，每股作价0.468港元， 总金额为1725.048万港元。增持后最新持股数目为3686万股，最新持股比例为6.55%。 ...

智通财经APP获悉，香港联交所最新资料显示，12月2日，曾阳庆增持中国环境资源(01130)3686万股， 每股作价0.468港元，总金额为1725.048万港元。增持后最新持股数目为3686万股，最新持股比例为 6.55%。 ...